To investigate the role of IκBα promoter polymorphisms in the development of Behçet's disease, eighty-six patients with Behçet's disease and 120 healthy controls were enrolled in this study. The IκBα -881A/G, -826C/T, -550A/T, -519C/T, and -297C/T polymorphisms were measured by the method of polymerase chain reaction/ restriction fragment length polymorphism. This study demonstrated that the genotype frequencies of IκBα -826C/T and -826T/T were significantly higher in the patients with Behçet's disease than in the controls. Both in the dominant and in the recessive models, the patients with Behçet's disease have higher frequencies of the IκBα -826T containing genotype than the controls. The allele frequency of IκBα -826T was significantly increased in the patients with Behçet's disease. The frequencies of the IκBα -881A -826T -550A -519C -297C and IκBα -881A -826T -550A -519T -297C haplotypes were significantly higher in the patients with Behçet's disease than in the controls. In contrast, the haplotype frequency of IκBα -881A -826C -550A -519C -297C in the patients with Behçet's disease was significantly decreased. This study also revealed that the Behçet's disease patients with IκBα -826T/T have higher prevalence of skin lesions than those without IκBα -826T/T. In summary, the IκBα -826T allele, IκBα -881A -826T -550A -519C -297C and IκBα -881A -826T -550A -519T -297C haplotypes might be associated with susceptibility to Behçet's disease. The IκBα -826T/T genotype was related to the development of skin lesions in the patients with Behçet's disease.
Introduction
Behçet's disease is a chronic inflammatory systemic autoimmune disease characterized primarily by recurrent oral ulcers, genital ulcers, ocular inflammation, skin lesions, and vasculitis. Although the etiology of Behçet's disease is still unknown, multiple genes and environmental factors are involved in the pathogenesis of this disease. HLA-B51 is strongly associated with susceptibility to Behçet's disease in different ethnic groups [1] . The positive rate of HLA-B51 in Behçet's disease is about 60% [2] . However, the contribution of this allele to the overall genetic susceptibility to Behçet's disease is only about 19% [3] . Therefore, non-HLA genes may also be related to the pathogenesis of this disease [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . A whole-genome screening also revealed the association of several non-HLA susceptibility loci with Turkish patients with Behçet's disease [14] .
Many pro-inflammatory cytokines are involved in the inflammatory process of Behçet's disease [13, [15] [16] [17] [18] . NFκB is related to the transcription of these proinflammatory cytokines, immune response, and antiapoptotic genes [19] [20] [21] [22] . Therefore, NFκB plays an important role in inflammatory diseases and in the development of autoimmunity [21, 23] . IκB is an inhibitor of NFκB, which binds with NFκB in the cytoplasm and influences the transcriptional activity of NFκB. Therefore, IκB may also play an important role in inflammatory immunological diseases.
The IκB family includes IκBα, IκBβ, IκBγ, IκBδ, IκBε, IκBζ, IκB-R, Bcl-3, p100, and p105 [24, 25] . All these proteins are characterized by the presence of multiple ankyrin repeats. IκBα, a classic form of the IκB family, consists of six ankyrin repeats, and can be found in cytoplasm and nucleus [25] .
Several polymorphisms in the promoter region of IκBα including -881A/G (rs 3138053), -826C/T (rs 2233406), -550A/T (rs 2233407), -519C/T (rs 2233408), and -297C/T (rs 2233409) have been identified [26] . Several transcription factor binding sites have been demonstrated in the promoter region of IκBα (TFsearch web). The IκBα promoter polymorphisms may affect IκBα expression and influence the regulation of inflammatory response. A mutation in the coding region of IκBα might result in the over-expression of IκBα, which was implicated in the development of lymphoma [27] .
Our previous studies showed that IκBα -826T might be associated with the development of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) in Taiwan [28, 29] . However, the correlation between IκBα promoter polymorphisms and Behçet's disease is still unknown. The purpose of the present study is to investigate the association of IκBα promoter polymorphisms with the development of Behçet's disease.
Material and methods
Eighty-six patients with Behçet's disease (59 females and 27 males; mean ± SD = 47.2 ± 12.9 years) and 120 unrelated healthy controls (84 females and 36 males; mean ± SD = 44.6 ± 10.1 years) were enrolled in this study. All of the patients and controls are Taiwanese. This study has been approved by the IRB of Kaohsiung Medical University Hospital. The diagnosis of Behçet's disease was made according to the International Study Group criteria for diagnosis of Behçet's disease [30] . The linkage disequilibrium in the promoter of IκBα could not be found in Chinese (HapMap). Therefore, the IκBα -881A/G, -826C/T, -550A/T, -519C/T, and -297C/T polymorphisms were detected in this study.
To determine the IκBα -881A/G and -826C/T polymorphisms, a set of primers with the following sequences: 5'-GGTCCTTAAGGTCCAATCG-3' and 5'-GTTGTGGATACCTTGCACTA-3' (underlined: mismatched nucleotide) were used. PCR was carried out under the following conditions: initial denaturation at 95
• C for 3 min and 5 cycles of denaturation at 95
• C for 1 min, annealing at 56
• C for 1 min, and extension at 72
• C for 1 min, and then 35 cycles of denaturation at 95
• C for 1 min, annealing at 54
• C for 1 min and extension at 72
• C for 1 min. A final extension phase was also performed at 72
• C for 7 min. The restriction enzymes, TspR I and Bfa I, were used to determine the IκBα -881A/G and IκBα -826C/T polymorphisms, respectively.
The primers 5'-GCTTTCACAACTTCTACCTG-3' and 5'-AGAGTGGAAA TGATGGCTG-3' were used to determine the IκBα -519C/T polymorphisms. The amplification conditions consisted of initial denaturation at 96
• C for 3 min, followed by 5 cycles of denaturation at 95
• C for 1 min, and 30 cycles of denaturation at 95
• C for 1 min, and then a final extension phase at 72
• C for 7 min. Then the PCR product was digested with Mnl I.
To determine the IκBα -550A/T polymorphisms, a nested PCR was performed with the PCR product for determining -519C/T polymorphisms and a set of new primers. The sequences of primers were 5'-TTGCTGCAAAGAGCCTGCT-3' (underlined: mismatched nucleotide) and 5'-AGAGTGGAAATGAT GGCTG-3'. The amplification conditions were as follows: initial denaturation at 96
• C for 1 min, annealing at 57
• C for 1 min, and then a final extension at 72
• C for 7 min. Then the PCR product was digested with Sfc I.
The primers 5'-GAAAGGACCGGCAGTTGG-3' and 5'-GTACTTCCCTG CAGCCTG-3' were used to determine the polymorphisms of IκBα -297C/T. The PCR was performed under the following conditions: initial denaturation at 96
• C for 1 min, followed by 30 
cycles of denaturation at 95
• C for 1 min, annealing at 52
• C for 7 min. The restriction enzyme Hpy8 I was used.
The polymorphisms of IκBα -826C/T measured by the PCR/RFLP method were also confirmed by direct sequencing.
The chi-square test or the Fisher's exact test was used for statistical analysis. The p-value was corrected by the multiplication of the number of comparisons (Pc). The OR was calculated by the method of Woolf and by a modification of the method of Haldane. The estimated haplotype frequencies were determined by the EH program (Web Resources of Genetic Linkage Analysis).
Results
The distributions of the genotypes in the controls and the patients were compatible with the Hardy-Weinberg equilibrium. In comparison with IκBα -826C/C, this study demonstrated that the genotype frequency of IκBα -826C/T was significantly higher in the patients with Behçet's disease than in the controls (Table 1 We also found that the patients with Behçet's disease had a significantly higher allele frequency of IκBα -826T than the controls (Table 2, p < 0.001, OR = 43.0, 95% CI = 23.2-79.8).
Direct sequencing was performed to verify the genotypes measured by the method of PCR/RFLP (Fig. 1) . The results of PCR/RFLP were compatible with those of direct sequencing.
This study demonstrated that the estimated haplotype frequency of IκBα -881A -826T -550A -519C -297C in the patients with Behçet's disease was significantly higher than that of the controls (p < 0.001, Pc < 0.006, OR = 34.14, 95% CI = 17.77-65.59). A similar finding could also be observed in the estimated haplotype frequency of IκBα -881A -826T -550A -519T -297C (Behçet's disease vs controls: p < 0.001, Pc < 0.006, NS: not significant. OR = 30.48, 95% CI = 3.93-236.52). In contrast, the estimated haplotype frequency of IκBα -881A -826C -550A -519C -297C was significantly decreased in the patients with Behçet's disease when compared with that of the controls (p < 0.001, Pc < 0.006, OR = 0.02, 95% CI = 0.01-0.04). The associations of the IκBα -826T/T genotype with the clinical manifestations of Behçet's disease were shown in Table 4 . The patients with Behçet's disease, carrying the IκBα -826T/T genotype, have higher prevalence of skin lesions including erythema nodosum, pseudofolliculitis, papulopustular lesion or acneiform nodules than the patients without IκBα -826T/T.
Sequences of I Bα

Discussion
This study demonstrated that the IκBα -826T allele, IκBα -881A -826T -550A -519C -297C haplotype and IκBα -881A -826T -550A -519T -297C haplotype might be related to susceptibility to Behçet's disease in Taiwan.
NFkB activation may modulate the expression of anti-apoptotic genes leading to apoptosis resistance in T-cell subsets of Behçet's disease, and plays an important role in the pathogenesis of Behçet's disease [31] . The anti-apoptogenic effect of NFkB is caused by the expression of anti-apoptogenic molecules including Bcl-xL, XIAP, IAP, and TRAFs [32] . IκB inhibits the transcription function of NFκB. Different IκB molecules preferentially inhibit the distinct NFkB/ Rel protein dimmer [24] . The central portions of IκB molecules contain several ankyrin repeats. The ankyrin repeats bind to the Rel homology domain of NFkB/ Rel, which causes NFkB to remain in the cytoplasm by masking the nuclear localization sequence of NFkB. Nuclear import of IκBα is also found [33, 34] . When IκBα is expressed in the nucleus, it can inhibit the interaction of NFkB with DNA and promote the export of NFkB from the nucleus to the cytoplasm [35] . The C-terminal domain of IκB may block DNA binding by NFkB and dissociate DNA-bound NFkB dimmers [36] .
Three NFkB binding sites, which are required for induction of gene expression, have been demonstrated in the promoter of IκBα [37] . A putative binding This study demonstrated that the IκBα -826T allele might be related to susceptibility to Behçet's disease. We also found that the IκBα -881A -826T -550A -519C -297C and IκBα -881A -826T -550A -519T -297C haplotypes played significant roles in the development of Behçet's disease. Our previous study showed that the IκBα -826T -550A -519C haplotype and IκBα -881A -826T -550A -519C -297C haplotype were associated with susceptibility to other autoimmune diseases in Taiwan [28, 29, 38] . These haplotypes may be related to the promoter activity of IκBα and the production of IκBα, and then influence the function of NFkB, which plays an important role in the inflammatory and immune responses. The promoter activities of various IκBα promoter polymorphisms were detected with a luciferase reporter assay. It showed that individuals with IκBα -826T allele had a lower promoter activity than those with IκBα -826C (unpublished data). Although the sample size of this study is limited, the power for the IκBα -826C/T polymorphisms is more than 95%. The numbers of patients and controls may suffice for this study.
Mutations in the IκBα are associated with other autoimmune diseases. An 8 bp insertion in the promoter region of IκBα (IκBα -708 ins 8) prevented the development of primary progressive multiple sclerosis [39] . The IκBα polymorphisms may also be associated with Crohn's disease or autoimmune diabetes mellitus [40, 41] . The single nucleotide polymorphisms in the 3 -UTR were significantly increased in these patients. Mutations of IκBα may also be associated with the development of other inflammatory diseases and malignancies [42, 43] . Mozzato-Chamay showed that the IκBα -881G/ -826T haplotype protected the development of scarring tracoma, an inflammatory disease, in Gambia [26] . The IκBα -881G -826T -297T haplotype was significantly associated with sarcoidosis in the UK and the Netherlands, and the IκBα -826T allele was related to the stage of sarcoidosis [44] . IκBα-deficient mice died of a wasting disease that was attributed to over-expression of TNFα [45] . Klement showed that IκBα deficiency also resulted in a sustained NFkB response and severe widespread dermatitis in mice [46] . This study also demonstrated that the IκBα -826T/T genotype was associated with the development of skin lesions in the patients with Behçet's disease.
The polymorphisms of IκBα have been demonstrated to be associated with some autoimmune diseases. The associations of these polymorphisms with various autoimmune diseases were summarized in Table 5 .
In conclusion, the IκBα -826T allele, IκBα -881A -826T -550A -519C -297C haplotype, and IκBα -881A -826T -550A -519T -297C haplotype may be related to susceptibility to Behçet's disease. In contrast, the IκBα -881A -826C -550A -519C -297C haplotype may prevent the development of Behçet's disease in Taiwan. Moreover, the IκBα -826T/T genotype is associated with skin lesions in patients with Behçet's disease.
